Domesticating Global Health Part 4

Wednesday, November 03, 2010 (5:00 PM - 7:00 PM)

Innovative Investing in Global Health: What’s in it for your organization?

- How does Global Health benefit Washington’s Life Science community and the state’s economy?
- What creative global health financing mechanisms are available to continue to partner and further leverage our innovation economy?

Global is also local – and innovation in our state is not only translating to lives saved worldwide but also can mean potential for business development.  Join us to hear recent developments on the strategies used to advance Washington’s Global Health initiatives and find out keys to success for product development in emerging markets.

  • During the 2010 session, the Legislature passed a global health competitiveness bill and created the Global Health Technologies Competitive Program Board designed to create a funding mechanism and a grant program to ensure that Washington remains competitive in global health innovation and to ensure that the development, manufacture, and delivery of global health products will become an even more dynamic part of the state's economy.
  • Learn about this competitive legislation and other key initiatives focused on global health investment.
Program Panelists:
  • Melinda Moree, CEO, BIO Ventures for Global Health (BVGH)- Moderator
  • Scott Jackson, VP for External Relations, PATH
  • Representative Phyllis Gutiérrez Kenney
  • John G. Abbott, Director, Standards & Regulations at Philips Healthcare

5:00-5:30pm – Registration | 5:30pm – Panel Presentation with reception to follow

Member registration: $50.00
Non-Member registration: $75.00
Student Rate: $25

We hope to see you there!

© 2012 Washington Biotechnology & Biomedical Association

Powered by